Safety Profiling of the <i>Ayurvedic</i> Formulation <i>Niruryadi Gulika</i> in Wistar Rats

Background: Niruryadi Gulika is a classical Ayurvedic formulation conventionally used for the treatment of diabetes mellitus. It is also used for the treatment of fever, respiratory ailments, along digestive ailments. This herbal medicine consists of a blend of potent herbs known for their antidiabetic, anti-inflammatory, antipyretic, and digestive properties. Niruri (Phyllanthus niruri) is one of its key ingredients, renowned for its hepatoprotective and antiviral effects. Along with other herbs, this formulation works to balance aggravated doshas, particularly Pitta and enhances overall vitality. Aim: In the present study, we have studied the acute and subacute safety profiling of Niruryadi Gulika in Wistar rats. Methods: During acute toxicity tests (2000 mg/kg b.w.) followed by monitoring for 2 weeks, Niruryadi Gulika showed no adverse effects on the overall health parameters of the rats. In subacute toxicity tests, Niruryadi Gulika was administered at 200 mg/kg body weight for 28 consecutive days. After the administration, animals were observed for the first 48 h, starting from half an hour for any toxic effect or altered behaviour, and the observation continued for a period of 24-48 h. Results: In post-treatment, serum haematological parameters and lipid profiling showed no significant differences with a transient rise in High-Density Lipoprotein (HDL), albumin, and chloride levels. No significant change is detected in any of the parameters when compared to the untreated animals. Conclusion: These results show that the Ayurvedic formulation is relatively nontoxic in Wistar rats and provides basic information on the toxicological profile of Niruryadi Gulika used in Ayurvedic medicine. Major Findings: Niruryadi Gulika showed no signs of acute or subacute toxicity in Wistar rats, confirming its safety and non-toxic nature. It also supported normal physiological and biochemical functions throughout the treatment period.

View article page

Download PDF